Home Cart Sign in  
Chemical Structure| 1224927-63-2 Chemical Structure| 1224927-63-2

Structure of 1224927-63-2

Chemical Structure| 1224927-63-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1224927-63-2 ]

CAS No. :1224927-63-2
Formula : C15H18BrNO3
M.W : 340.21
SMILES Code : O=C(OC(C)(C)C)CN1C(CCC2=C1C=CC(Br)=C2)=O
MDL No. :MFCD26392965
InChI Key :FHVGZKJWHYJCCN-UHFFFAOYSA-N
Pubchem ID :59316597

Safety of [ 1224927-63-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1224927-63-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 20
Num. arom. heavy atoms 6
Fraction Csp3 0.47
Num. rotatable bonds 4
Num. H-bond acceptors 3.0
Num. H-bond donors 0.0
Molar Refractivity 84.5
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

46.61 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

3.18
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.85
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.69
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.75
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.19
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.93

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.7
Solubility 0.0674 mg/ml ; 0.000198 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.49
Solubility 0.111 mg/ml ; 0.000325 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.58
Solubility 0.00903 mg/ml ; 0.0000265 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.35 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.45

Application In Synthesis of [ 1224927-63-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1224927-63-2 ]

[ 1224927-63-2 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 3279-90-1 ]
  • [ 5292-43-3 ]
  • [ 1224927-63-2 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With sodium hydride In N,N-dimethyl-formamide for 0.5 h; Inert atmosphere
Stage #2: at 20℃;
A.
Synthesis of tert-butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate
To a mixture of 95percent dry sodium hydride (834 mg, 33.0 mmol) in anhydrous N,N-dimethylformamide (30 mL) at room temperature was added a solution of 6-bromo-3,4-dihydroquinolin-2(1H)-one (6.780 g, 30.00 mmol) in anhydrous N,N-dimethylformamide (10 mL).
The reaction mixture was stirred for 30 minutes under an atmosphere of dry N2, followed by addition of a solution of tert-butyl 2-bromoacetate (7.5 mL, 49.7 mmol) in N,N-dimethylformamide (10 mL).
The reaction mixture was stirred at room temperature until the majority of the starting material was converted (confirmed by LCMS).
The reaction mixture was quenched with methanol (40 mL), the mixture concentrated under reduced pressure, then diluted with ethyl acetate (150 mL).
The organic phase was washed with water (100 mL), 30percent ammonium chloride (100 mL) and brine (100 mL), dried, and concentrated under reduced pressure.
Ethyl ether (20 mL) was added, and the mixture sonicated, filtered, washed with ether (20 mL), and dried to afford tert-butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate (7.348 g, 21.6 mmol, 72percent). LCMS mz 285.9 (M-56+H), 363.9 (M+Na), anal HPLC>97percent in purity. 1H NMR (400 MHz; CDCl3) δ 7.30-7.40 (m, 2H); 7.50-6.70 (m, 1H); 4.54 (s, 2H); 2.92 (m, 2H); 2.69 (m, 2H), 1.44 (s, 9H).
References: [1] Patent: US2010/113514, 2010, A1, . Location in patent: Page/Page column 17.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1224927-63-2 ]

Bromides

Chemical Structure| 1123169-45-8

A424289 [1123169-45-8]

tert-Butyl 6-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.74

Chemical Structure| 1187932-64-4

A219947 [1187932-64-4]

tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.73

Chemical Structure| 135631-90-2

A127606 [135631-90-2]

6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Chemical Structure| 14548-51-7

A151306 [14548-51-7]

7-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Chemical Structure| 897957-06-1

A111788 [897957-06-1]

6-Bromo-1-methylindolin-2-one

Similarity: 0.72

Amides

Chemical Structure| 109010-60-8

A280526 [109010-60-8]

(S)-tert-Butyl 2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate

Similarity: 0.76

Chemical Structure| 1123169-45-8

A424289 [1123169-45-8]

tert-Butyl 6-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.74

Chemical Structure| 1187932-64-4

A219947 [1187932-64-4]

tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.73

Chemical Structure| 135631-90-2

A127606 [135631-90-2]

6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Chemical Structure| 14548-51-7

A151306 [14548-51-7]

7-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Esters

Chemical Structure| 109010-60-8

A280526 [109010-60-8]

(S)-tert-Butyl 2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate

Similarity: 0.76

Chemical Structure| 898747-32-5

A159194 [898747-32-5]

Methyl 5-bromo-2-oxoindoline-7-carboxylate

Similarity: 0.72

Chemical Structure| 1033265-51-8

A136767 [1033265-51-8]

tert-Butyl 5-bromo-1H-indole-3-carboxylate

Similarity: 0.69

Chemical Structure| 16732-70-0

A155484 [16732-70-0]

Ethyl 5-bromo-1H-indole-2-carboxylate

Similarity: 0.68

Chemical Structure| 103858-53-3

A196544 [103858-53-3]

Ethyl 6-bromoindole-2-carboxylate

Similarity: 0.66

Related Parent Nucleus of
[ 1224927-63-2 ]

Tetrahydroquinolines

Chemical Structure| 1123169-45-8

A424289 [1123169-45-8]

tert-Butyl 6-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.74

Chemical Structure| 1187932-64-4

A219947 [1187932-64-4]

tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate

Similarity: 0.73

Chemical Structure| 135631-90-2

A127606 [135631-90-2]

6-Bromo-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Chemical Structure| 14548-51-7

A151306 [14548-51-7]

7-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.73

Chemical Structure| 880094-83-7

A122666 [880094-83-7]

5-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.70